# 20/20 Biolabs, Inc.: Form S-1, filed Apr 6, 2026

- Company: [20/20 Biolabs, Inc.](/companies/aidx.md) (CIK 1139685)
- Form: S-1
- Filed: 2026-04-06
- Accepted by EDGAR: Apr 6, 2026, 21:28 ET
- Period: not reported
- Accession: 0001213900-26-040553
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026040553/ea0284915-s1_2020bio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1139685/000121390026040553/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1139685/000121390026040553/ea0284915-s1_2020bio.htm

Filed Apr 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-040553. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.